Mental Health & Substance Abuse Management Summit
Best Practices and Innovations in Mental Health and Wellness for Providers, Health Plans and Employers
October 26 – 27, 2020

Mental Health & Substance Abuse Management Summit

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

About the Conference

Millions of people in the U.S. are affected by mental illness each year. Mental health illness and substance use disorders affect people of all ages and demographics and are extremely burdensome to society and socioeconomic costs. More than one in four adults living with serious mental health problems also has a substance use problem. Because of this, behavioral health integration and management has moved to the forefront as the healthcare industry strives to advance the coordination of behavioral healthcare services and implementation of integration initiatives to improve access to treatment.

This conference will bring together some of the leading national experts responding to this ever-increasing public health crisis to provide insights on policy, operations, and management of mental health strategies to reduce the impact of mental and substance use disorders on America’s communities. Join your peers to shape the future of mental health and hear how to address the opioid epidemic, collaboration with community partners, treating co-occurring disorders, value-based care, workplace wellness, social determinants and more.

Who Should Attend?

From Hospitals/Health Systems/Health Plans/Gov’t Agencies/Psychiatrists/Employers/Law Enforcement/Education Facilities/Rehab Facilities/Counseling Centers

  • CEO
  • CFO
  • VP
  • Medical Directors
  • Behavioral Health Directors
  • Pharmacy Directors
  • Clinical Pharmacists
  • Mental Health Counselors
  • Social Workers
  • Outreach Coordinators
  • PDMP Directors
  • Pain Management Directors
  • Psychiatrists
  • Psychologists
  • Telehealth Directors
  • State Health Directors
  • Nursing Director
  • Employee Assistance Programs
  • HR/Benefits
  • Emergency Room Directors
  • Substance Abuse & Prevention Directors
  • Pediatricians
  • Law Enforcement
  • Narcotic Enforcement
  • Physicians
  • Quality Improvement Director
  • Occupational Health
  • Family Services Director
  • Clinical Directors
  • Investigators
  • Compliance Director
  • Correctional Coordinators

This Event Will Also be if Interest to:

  • Pharmaceutical Companies * Law Firms * Consultants * Drug Development Companies

Conference Agenda

Day One – Monday, October 26, 2020

10:00am – 10:05am
Opening Remarks

10:05am – 10:50am
Self-Care is Prevention in Action (SPA): A Holistic Approach to Workplace Wellness

This presentation is an in-depth look at the work from the partnership between Georgia State University and Newton County Schools, highlighting the physiological effects of stress on educators and employees in the workplace. Newton County Schools, Project AWARE LEA, and GSU Service Learning Students collected and analyzed survey data to determine the needs of educators within the school system. Like many other helping professions, educators often experience high levels of empathy, compassion satisfaction, burnout, and compassion fatigue. This presentation will take an interactive and holistic approach to address personal accountability – the belief in one’s ability to influence the world around them, improve relationships, achieve goals, and set their own trajectory in life – an essential and often overlooked element of employee well-being. Learn how to transform your organization’s culture for heightened accountability, alignment, and engagement, impacting employees’ lives at work… and at home.

Chris Williams
Math and Science Instructional Coach/Lead Educational Consultant
Newton County Schools/EPIC Educators LLC.

10:55am – 11:40am
Meditate, Not Medicate, Pain Away

The current opiate crisis has left both doctors and patients struggling and frustrated. Doctors around the country are struggling to follow FDA guidelines and state regulations restricting their ability to write prescriptions for their patients. Patients, on the other hand, are frustrated or worse because for thousands of them, the medications that were allowing them to function are suddenly being taken away, and they have been left to either find them on the street or suffer. Fortunately, there is increasing evidence that alternative treatment modalities may fill this gap. CBT, Mindfulness based therapies, CBT, acupuncture – these are some of these alternative treatment approaches that work to reduce pain and suffering without the risks associated with narcotics. This talk will focus on the use of tools to manage chronic pain and suffering.

Pranav V. Shah, MD
Department of Psychiatry
Southern California Permanente Medical Group Orange County
Kaiser Permanente

11:45am – 12:30pm
The Importance of Early Assessment and Treatment of Mental Illness

Mental illness has been viewed as a disease of early adulthood. But the onset of these illnesses typically occurs in teens and young adults. In fact, about half of all lifetime cases of mental illnesses start at age 14. Symptoms in three-quarters of mental illness cases appear by age 24. About one in 10 children and teens suffer from mental illness severe enough to cause some level of impairment. Early detection and treatment of mental disorders can result in a substantially shorter and less disabling course of illness. As the mental health field becomes increasingly able to identify the early antecedents of mental illnesses at any age, interventions must be implemented, provided in multiple settings, and connected to treatment and supports. This session will examine how early interventions and educational efforts can help a greater number of parents, the public, and providers learn about the importance of the first years of a child’s life and how to establish a foundation for healthy social and emotional development.

12:30pm – 1:00pm
Lunch Break

1:00pm – 1:45pm
Building meaningful incentives to behavioral health integration

The Integrating Behavioral Health into General Medical Care Initiative was started in 2015 to guide physician organizations through a participation-based collaborative process to focus work on specific, self-identified measures. Sixteen Physician Organizations, representing about 150 practice units and reaching approximately 280,000 patients have actively collaborated this cohort-based effort. Beginning in 2020, this work will primarily promote the Psychiatric Consultant Model, which is also known as CoCare. One of our goals is to scale this work to an additional 500 practice units. We will provide training on and onsite support for this provider-delivered care management model. Additionally, we are building a set of incentives to reward physician organizations to promote this work, offset some of the costs of the practices as they modify workflows and make other changes needed to use the model, and reward the PCPs and consulting psychiatrists using the model.

Kathleen Kobernik
Senior Health Care Analyst
Blue Cross Blue Shield of Michigan

1:50pm – 2:35pm
Scope of the Opioid Epidemic

This presentation will review “The Perfect Storm,” which resulted in the opioid epidemic in the United States. The relationship between prescription opioids, then heroin, and now fentanyl will be described. Evidence for both the effectiveness and safety of chronic opioid therapy to treat chronic non-cancer pain will be assessed. Intended and unintended consequences of the efforts to stem the tide of overdose deaths will be defined. Treatment strategies based on the CDC Guidelines for Treating Chronic Pain will be discussed.

Edwin A. Salsitz, MD, DFASAM
Associate Clinical Professor
Mount Sinai Beth Israel

2:40pm – 3:25pm
Collaboration Between Opioid Treatment Programs and Community Partners

In response to the heightened risks associated with the use of opioids, this session will discuss community safety strategies to reduce the harm imposed by opioids on communities and help to control the opioid epidemic. Topics will include:
- Best practice in opioid prescribing and monitoring to reduce the quantity of opioids in circulation
- Strategies to assist healthcare partnerships and collaborations by advancing their understanding of medication-assisted treatment as a crucial element to community wellness in an era of healthcare reform
- The essential role that the community plays in recovery support and prevention

Ghazala Nathu, MD, MS, PhD, FACB
Clinical/Molecular Pathology Director, Laboratory Services
Director of Opioid Waterford Medical Clinic
Bassett Healthcare Network – Cobleskill Regional Hospital

3:30pm – 4:15pm
Understanding the Neurobiological Underpinnings of Addiction and How they Relate to Treatment

There are FDA approved medications for the management of substance use disorders, including alcohol, tobacco, and opioid use disorder. Their underlying mechanisms target neurobiological changes that occur with chronic substance use. Understanding some of these neurobiological underpinnings is crucial in appreciating the compulsive nature of the disease. In combination with social factors associated with substance use, the brain disease model of addiction provides a foundation off of which we can treat patients with compassion, and with which we can implement pharmacological interventions that help individuals regain function and establish recovery from substance use.

Claudia P. Rodriguez, MD
Director of Addiction Services
Brigham and Women’s Faulkner Hospital

4:20pm – 5:05pm
Panel: Making Behavioral Health Part of Workplace Wellness

This session will examine how employers can and should address the total health of employee populations by addressing mental health issues and emotional wellness. Topics to be addressed will include:
- Ensuring employees have access to mental health benefits including an employee assistance program (EAP)
- Making behavioral health a priority to enhance employee well-being and boost productivity
- How focusing on addressing behavioral health can reduce costs
- Leveraging telemedicine to offer employees instant access to mental health coaching and educational resources

5:05pm
End of Day One

Day Two – Tuesday, October 27, 2020

10:00am – 10:05am
Recap of Day One

10:05am – 10:50am
Classic and Contemporary MAT for Opioid and Polysubstance Use Disorder In Post-Fentanyl America

This introductory lecture is a case-based discussion of the general approach to evaluation and treatment of patients presenting with problematic opioid use. Benefits and limitations of available medications and differences between them are described. An approach to choosing first and second line treatments will also be presented.
Educational Objectives:
• Describe the components of evaluation for medication assisted treatment
• Discuss the range of treatment goals for patients with OUD
• Identify the FDA-approved pharmacological treatments for OUD
• Demonstrate an understanding of the benefits and limitations of all available treatments and differences between them
• Describe the different first and second-line approaches to treat OUD and the process of shared decision making

William Morrone, DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABA, DAAPM
Medical Director
Recovery Pathways and the Shiawassee 35th Circuit Drug Court
Assistant Professor of Nursing
Johns Hopkins University
Faculty, Family and Community Medicine
Michigan State University College of Osteopathic Medicine
Assistant Program Director of Family Medicine
Synergy Medical Education Alliance

10:55am – 11:40am
Transitioning from A Fee-For-Service Mindset To Value-Based Care

The U.S. is moving toward a value-based care system. Behavioral health providers and their payors are expected to prepare for the future by identifying meaningful and achievable clinical outcomes and analyzing data in real-time. This session will examine a spectrum of value-based strategies to promote quality, cost-efficient behavioral health treatment. Examples of value-based payment models will be discussed for a variety of behavioral health service settings.

Alin J. Severance, MD
Associate Medical Director
Community Care Behavioral Health Organization

11:45am – 12:30pm
There’s No Health Without Mental Health: Freddie Mac’s Journey to Reducing the Stigma

Responsible companies care about and support the health and well-being of their employees. That includes physical, financial and mental health. We know for some there is a stigma attached to mental health issues, and people are often reluctant to talk about them or seek treatment. At Freddie Mac, we are committed to a stigma free, inclusive culture where we endeavor to understand and support those facing the challenges associated with mental health conditions.

Dan Scheinkman
Vice President, Compensation, Benefits, and Well-Being
Freddie Mac

Barbara Steacy
Benefits Senior, Well-Being and Rewards and Recognition
Freddie Mac

12:35pm – 1:20pm
The Expanding Role of Buprenorphine in Pain Management

The role of buprenorphine is continuing to expand. While it has been used for many years in those suffering from an opioid use disorder, adoption for use in the treatment of pain has been slow. Lack of familiarity and payor coverage issues have hampered consideration of this medication in the treatment of pain despite having a favorable safety profile in comparison to other opioid agonists. Clinical pharmacists can play an integral role in product selection, monitoring parameters, and patient education about opioid therapy. This session will feature a clinical pharmacist who will discuss buprenorphine for the treatment of chronic pain and assess the differences between available buprenorphine products.

Jason Hoch, PharmD
Clinical Pharmacist-Addiction Medicine
Clinical Assistant Professor of Pharmacy
Geisinger Bloomsburg Hospital

1:25pm
Conference Concludes

Workshop – Tuesday, October 27, 2020

1:00pm – 3:30pm
The Connection Between Substance Use Disorders and Mental Illness and Treating Co-Occurring Disorders

Many individuals who develop substance use disorders (SUD) are also diagnosed with mental disorders, and vice versa. Multiple national population surveys have found that about half of those who experience a mental illness during their lives will also experience a substance use disorder and vice versa. Many separate and parallel mental health and substance abuse treatment systems do not offer interventions that are accessible, integrated, and tailored for the presence of co-occurrence. This workshop will offer guidance related to treating co-occurring disorders, including training, specific programs, and quality improvement.

Featured Speakers

Chris Williams

Chris Williams

Math and Science Instructional Coach/Lead Educational Consultant

Newton County Schools/EPIC Educators LLC.

Pranav V. Shah, MD

Pranav V. Shah, MD

Department of Psychiatry, Southern California Permanente Medical Group Orange County

Kaiser Permanente

Edwin A. Salsitz, MD, DFASAM

Edwin A. Salsitz, MD, DFASAM

Associate Clinical Professor

Mount Sinai Beth Israel

Claudia P. Rodriguez, MD

Claudia P. Rodriguez, MD

Director of Addiction Services

Brigham and Women’s Faulkner Hospital

Louis A. Amis

Louis A. Amis

Director of Employee Benefits

City of Atlanta

Kathleen Kobernik

Kathleen Kobernik

Senior Health Care Analyst

Blue Cross Blue Shield of Michigan

William Morrone, DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABA, DAAPM

William Morrone, DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABA, DAAPM

Medical Director

Recovery Pathways and the Shiawassee 35th Circuit Drug Court
Assistant Professor of Nursing
Johns Hopkins University
Faculty, Family and Community Medicine
Michigan State University College of Osteopathic Medicine
Assistant Program Director of Family Medicine
Synergy Medical Education Alliance

Alin J. Severance, MD

Alin J. Severance, MD

Associate Medical Director

Community Care Behavioral Health Organization

Dan Scheinkman

Dan Scheinkman

Vice President, Compensation, Benefits, and Well-Being

Freddie Mac

Barbara Steacy

Barbara Steacy

Benefits Senior, Well-Being and Rewards and Recognition

Freddie Mac

Jason Hoch, PharmD

Jason Hoch, PharmD

Clinical Pharmacist-Addiction Medicine, Clinical Assistant Professor of Pharmacy

Geisinger Bloomsburg Hospital

Jennifer Esper

Jennifer Esper

Chief Executive Officer

Esper Treatment Center

Ghazala Nathu, MD, MS, PhD, FACB

Ghazala Nathu, MD, MS, PhD, FACB

Clinical/Molecular Pathology Director, Laboratory Services, Director of Opioid Waterford Medical Clinic

Bassett Healthcare Network – Cobleskill Regional Hospital

Venue

TBA

Sponsors and Exhibitors

Exhibitors

 

Orexo US, Inc. Orexo US, Inc., a specialty pharmaceutical company with a mission to advance the treatment of opioid dependence and support patient care. We recognize opioid dependence is a long standing problem and have made a commitment to advancing evidence based treatment.

 

Deja Skin therapy using micro and magnetic currents, LED light therapy and CBD mineral skin care.

 

FAQ

Are there group discounts available?

  • Yes – Register a group of 3 or more at the same time and receive an additional 10% off the registration fee

Are there discounts for Non-Profit/Government Organizations?

  • Yes – please call us at 800-743-8490 for special pricing

What is the cancellation policy?

  • Cancellations received 3 weeks prior to the event will receive a refund minus the administration fee of $185. Cancellation received less than 3 weeks prior to the event will receive a credit to a future event valid for one year.

Can the registration be transferred to a colleague?

  • Yes – please email us in writing at info@brinetwork.com with the colleague’s name and title

Where can I find information on the venue/accommodations?

  • Along with your registration receipt you will receive information on how to make your hotel reservations. You can also visit individual event page for specific hotel information. The conference fee does not include the cost of accommodations.

What is the suggested dress code?

  • Business casual. Meeting rooms can sometimes be cold so we recommend a sweater or light jacket

Request Brochure

Register Your Team Today!

Register Now

Special Discount Offer – Mention Promo Code WB100 for an additional $100 off the registration fee!

Ask A Question

Be A Thought Leader And Share!

Pin It on Pinterest